Theodore Schroeder
Overview
Theodore Schroeder received an average of $2M in total compensation, including $488K in salary, at Nabriva Therapeutics AG from 2018 to 2021.
Source: SEC filings on July 11, 2022, June 25, 2020, and June 14, 2019.
Related executives
We found eight more executives who work or worked at Nabriva Therapeutics AG.
Steven Gelone
Nabriva Therapeutics AG
Chief Operating Officer
Daniel Dolan
Nabriva Therapeutics AG
Chief Financial Officer
Jennifer Schranz
Nabriva Therapeutics AG
Chief Medical Officer
Colin Broom
Nabriva Therapeutics AG
Chief Executive Officer
Francesco Lavino
Nabriva Therapeutics AG
Chief Commercial Officer
Elyse Seltzer
Nabriva Therapeutics AG
Chief Medical Officer
Gary Sender
Nabriva Therapeutics AG
Chief Financial Officer
Peter Wolf
Nabriva Therapeutics AG